Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Frontiers in Oncology|May 10, 2021
SEMMs: Somatically Engineered Mouse Models. A New Tool for In Vivo Disease Modeling for Basic and Translational ResearchAnthony Lima, Danilo MaddaloFrontiers in Genetics|November 1, 2023
Applications of CRISPR-Cas9 for advancing precision medicine in oncology: from target discovery to disease modelingMirunalini Ravichandran, Danilo MaddaloFrontiers in Pharmacology|February 14, 2013
The Molecular Chaperone GRP78/BiP in the Development of Chemoresistance: Mechanism and Possible TreatmentCorinna Roller, Danilo MaddaloCancer Research|August 14, 2016
Somatic Engineering of Oncogenic Chromosomal Rearrangements: A PerspectiveDanilo Maddalo, Andrea VenturaThe CRISPR Journal|August 2, 2022
The CRISPR Revolution in the Drug Discovery Workflow: An Industry PerspectiveAnnalisa Lattanzi, Danilo MaddaloCurrent Protocols|March 7, 2022
In Vivo Modeling of Tumor Heterogeneity for Immuno-Oncology Studies: Failures, Improvements, and HopesAshley V DiMarco, Danilo MaddaloJournal of Visualized Experiments : Jove|February 3, 2012
Intracellular refolding assayTamara Vanessa Walther, Danilo MaddaloFuture Science OA|July 23, 2021
Drug discovery oncology in a mouse: concepts, models and limitationsJason E Long, Maja Jankovic, Danilo MaddaloBiochimica Et Biophysica Acta. Molecular Cell Research|August 2, 2017
The E3 ubiquitin ligase MID1/TRIM18 promotes atypical ubiquitination of the BRCA2-associated factor 35, BRAF35Melania E Zanchetta, Luisa M R Napolitano, Danilo Maddalo, et al.Cancer Discovery|September 8, 2023
SHP2: A Pleiotropic Target at the Interface of Cancer and Its MicroenvironmentNicole M Sodir, Gaurav Pathria, Joanne I Adamkewicz, et al.Pageof 4